ACTRN12613000198729	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Dabrafenib; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:Nivolumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:Trametinib
ACTRN12613000297729	*NOT prior_therapy:Bevacizumab
ACTRN12613000556741	*NOT prior_therapy:Capecitabine; *NOT prior_therapy:Panitumumab; *prior_therapy:Cetuximab; *prior_therapy:Oxaliplatin
ACTRN12614000365662	*NOT prior_therapy:Paclitaxel
ACTRN12614001181695	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
ACTRN12614001292662	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Taxane
ACTRN12615000504516	*NOT prior_therapy:Paclitaxel; *NOT prior_therapy:Taxane; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12615001072505	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Carboplatin
ACTRN12615001291572	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:FGFR_inhibitor; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12616000228482	*NOT prior_therapy:Bevacizumab
ACTRN12616000420448	*NOT prior_therapy:Apatinib; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12616000958482	*NOT prior_therapy:systemic_therapy
ACTRN12616001019493	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:Olaparib; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
ACTRN12616001637437	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
ACTRN12617000855325	*NOT prior_therapy:Denosumab; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12617001000392	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:Olaparib
ACTRN12617001181392	*NOT prior_therapy:immune_checkpoint_blockade
ACTRN12617001190392	*NOT prior_therapy:Cetuximab; *NOT prior_therapy:Erlotinib; *NOT prior_therapy:Panitumumab; *NOT prior_therapy:platinum-based_antineoplastic_agent
ACTRN12617001325392	*NOT prior_therapy:Olaparib; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
ACTRN12617001573347	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:Oxaliplatin
ACTRN12618000053224	*prior_therapy:anti-PD-1_monoclonal_antibody
ACTRN12618000233224	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Panitumumab; *NOT prior_therapy:systemic_therapy
ACTRN12618000357257	*NOT prior_therapy:Taxane
ACTRN12618000686202	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
ACTRN12618000954224	*NOT prior_therapy:Ipilimumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12618000977279	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
ACTRN12618001073291	*NOT prior_therapy:Taxane
ACTRN12618001121257	*NOT prior_therapy:Denosumab; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12618001480279	*NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:systemic_therapy
ACTRN12618001573246	*NOT prior_therapy:Crizotinib; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:Olaparib; *NOT prior_therapy:endocrine_therapy
ACTRN12618001742268	*NOT prior_therapy:Afatinib; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12619000566134	*NOT prior_therapy:Oxaliplatin
ACTRN12619000567123	*NOT prior_therapy:Apalutamide; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Taxane
ACTRN12619000640101	*NOT prior_therapy:Bevacizumab
ACTRN12619000844145	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Lorlatinib
ACTRN12619000900112	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12619001117101	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:Capecitabine; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:mTOR_inhibitor
ACTRN12619001185156	*prior_therapy:platinum-based_antineoplastic_agent
ACTRN12619001265167	*NOT prior_therapy:Lapatinib; *NOT prior_therapy:Neratinib; *NOT prior_therapy:Pertuzumab; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2
ACTRN12619001407189	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
ACTRN12619001527156	*NOT prior_therapy:EGFR_inhibitor
ACTRN12620000568910	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:mTOR_inhibitor
ACTRN12620000592943	*NOT prior_therapy:Paclitaxel
ACTRN12620000767909	*NOT prior_therapy:anti-HER2
ACTRN12620000849998	*NOT prior_therapy:Sorafenib
ACTRN12620000861954	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor
ACTRN12620000918921	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:Olaparib; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
ACTRN12621000156886	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
ACTRN12621000269831	*NOT prior_therapy:Bevacizumab; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12621000284864	*NOT prior_therapy:ROS1_inhibitor
ACTRN12621000312842	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Alectinib
ACTRN12621000479808	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:systemic_therapy
ACTRN12621000507886	*NOT prior_therapy:Durvalumab
ACTRN12621000611820	*NOT prior_therapy:Dasatinib
ACTRN12621000639820	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:mTOR_inhibitor; *prior_therapy:platinum-based_antineoplastic_agent
ACTRN12621000747820	*NOT prior_therapy:Apalutamide; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Taxane
ACTRN12621000811808	*NOT prior_therapy:MET_inhibitor
ACTRN12621001155886	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:anti-PD-1_monoclonal_antibody
ACTRN12621001225808	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
ACTRN12621001290886	*NOT prior_therapy:systemic_therapy
ACTRN12621001347853	*NOT prior_therapy:Gemcitabine
ACTRN12621001537842	*NOT prior_therapy:immune_checkpoint_blockade
ACTRN12621001690842	*NOT prior_therapy:MEK_inhibitor
ACTRN12622000016730	*NOT prior_therapy:Paclitaxel; *NOT prior_therapy:Pertuzumab; *NOT prior_therapy:Tamoxifen; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:systemic_therapy
ACTRN12622000513718	*NOT prior_therapy:Paclitaxel; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12622000973718	*NOT prior_therapy:systemic_therapy
ACTRN12622000993796	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12622001003763	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide
ACTRN12623000223639	*NOT prior_therapy:systemic_therapy
NCT02215447	*NOT prior_therapy:systemic_therapy
NCT02216487	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:systemic_therapy
NCT02254785	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide
NCT02365441	*NOT prior_therapy:systemic_therapy
NCT02375204	*NOT prior_therapy:Carboplatin; *prior_therapy:Cisplatin
NCT02408861	*NOT prior_therapy:Nivolumab; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT02516553	*NOT prior_therapy:Apalutamide; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Denosumab; *NOT prior_therapy:Taxane; *prior_therapy:Oxaliplatin
NCT02582697	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin
NCT02609776	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Amivantamab; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Lazertinib; *NOT prior_therapy:Poziotinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent; *prior_therapy:Erlotinib; *prior_therapy:Osimertinib
NCT02611960	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT02628067	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT02702414	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:Sorafenib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT02775435	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Crizotinib; *NOT prior_therapy:Erlotinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT02787005	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT02861573	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT02964013	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT03036098	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT03069469	*NOT prior_therapy:Nilotinib
NCT03093116	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03110107	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03157128	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03175224	*NOT prior_therapy:EGFR_inhibitor
NCT03188159	*prior_therapy:platinum-based_antineoplastic_agent
NCT03212404	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT03261011	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT03278717	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:PARP_inhibitor; *prior_therapy:platinum-based_antineoplastic_agent
NCT03281369	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03286842	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:mTOR_inhibitor
NCT03319628	*NOT prior_therapy:Taxane; *NOT prior_therapy:mirvetuximab; *prior_therapy:Bevacizumab; *prior_therapy:platinum-based_antineoplastic_agent
NCT03319940	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03358875	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT03363867	*NOT prior_therapy:Atezolizumab; *NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Cobimetinib; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03377491	*NOT prior_therapy:Gemcitabine; *NOT prior_therapy:Paclitaxel
NCT03390504	*NOT prior_therapy:FGFR_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03448042	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03484923	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:anti-PD-L1_monoclonal_antibody
NCT03486873	*NOT prior_therapy:Pembrolizumab
NCT03497767	*NOT prior_therapy:Osimertinib; *NOT prior_therapy:immune_checkpoint_blockade
NCT03522064	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03529526	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT03530397	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Durvalumab
NCT03539536	*NOT prior_therapy:telisotuzumab
NCT03551626	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT03564340	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:PARP_inhibitor; *prior_therapy:platinum-based_antineoplastic_agent
NCT03564691	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT03682068	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03706365	*NOT prior_therapy:Abemaciclib; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide
NCT03708328	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03735121	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT03739710	*NOT prior_therapy:Docetaxel
NCT03742895	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:endocrine_therapy
NCT03748134	*NOT prior_therapy:Cisplatin; *NOT prior_therapy:systemic_therapy
NCT03755791	*NOT prior_therapy:immune_checkpoint_blockade
NCT03787602	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT03816163	*NOT prior_therapy:Zolbetuximab; *NOT prior_therapy:systemic_therapy
NCT03821233	*NOT prior_therapy:Pertuzumab; *NOT prior_therapy:anti-HER2
NCT03821935	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03833154	*NOT prior_therapy:Osimertinib; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03845166	*NOT prior_therapy:Avelumab; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Gemcitabine; *NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:Panitumumab; *NOT prior_therapy:Regorafenib; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03850795	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Bicalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Flutamide; *NOT prior_therapy:Nilutamide
NCT03874884	*NOT prior_therapy:Bicalutamide; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Flutamide; *NOT prior_therapy:Nilutamide; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03875079	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03878719	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Dabrafenib; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:Trametinib; *NOT prior_therapy:Vemurafenib
NCT03900884	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:aromatase_inhibitor
NCT03918278	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Gemcitabine; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03947385	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Crizotinib; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT03964233	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03964727	*NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:topoisomerase I inhibitor
NCT03974022	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Poziotinib; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03975647	*NOT prior_therapy:Afatinib; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Pyrotinib; *NOT prior_therapy:Taxane; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:Tucatinib
NCT03994393	*NOT prior_therapy:Afatinib; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04000529	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04032704	*prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04047290	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04047862	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04049617	*NOT prior_therapy:Neratinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04052971	*NOT prior_therapy:MET_inhibitor
NCT04100018	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04106492	*NOT prior_therapy:anti-HER2; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04109456	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04113616	*NOT prior_therapy:Decitabine
NCT04122339	*NOT prior_therapy:Erlotinib; *NOT prior_therapy:Lapatinib
NCT04123366	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *prior_therapy:Cisplatin; *prior_therapy:Oxaliplatin; *prior_therapy:platinum-based_antineoplastic_agent
NCT04140526	*NOT prior_therapy:Pembrolizumab
NCT04154956	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04157517	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04188548	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:Pertuzumab; *NOT prior_therapy:Taxane; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *prior_therapy:platinum-based_antineoplastic_agent
NCT04191499	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:Tamoxifen; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:mTOR_inhibitor; *NOT prior_therapy:selective_estrogen-receptor_degrader
NCT04205227	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04211337	*NOT prior_therapy:systemic_therapy
NCT04215978	*NOT prior_therapy:anti-OX40_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04221035	*NOT prior_therapy:Carboplatin
NCT04221542	*NOT prior_therapy:Apalutamide; *NOT prior_therapy:Bicalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane
NCT04222972	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04223856	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:enfortumab; *NOT prior_therapy:systemic_therapy
NCT04242199	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04249843	*NOT prior_therapy:BRAF_inhibitor
NCT04251117	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Sorafenib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT04269200	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04282018	*NOT prior_therapy:PI3K_inhibitor
NCT04294810	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04305054	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:systemic_therapy
NCT04334759	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:Nivolumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04343885	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:systemic_therapy
NCT04370704	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04390763	*NOT prior_therapy:Gemcitabine; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:systemic_therapy
NCT04402073	*NOT prior_therapy:Imatinib; *NOT prior_therapy:systemic_therapy
NCT04417621	*NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04419402	*NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide
NCT04427072	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:MET_inhibitor
NCT04428151	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04432207	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04434482	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04446117	*NOT prior_therapy:Apalutamide; *NOT prior_therapy:Bicalutamide; *NOT prior_therapy:Flutamide
NCT04450732	*NOT prior_therapy:Paclitaxel
NCT04458259	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04468607	*prior_therapy:Oxaliplatin
NCT04493853	*NOT prior_therapy:Abiraterone
NCT04494425	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2
NCT04497844	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:PARP_inhibitor
NCT04499352	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Sunitinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04501276	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT04505826	*NOT prior_therapy:endocrine_therapy
NCT04513925	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT04516447	*prior_therapy:platinum-based_antineoplastic_agent
NCT04521686	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:Gemcitabine; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04522323	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:mTOR_inhibitor
NCT04524689	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04526106	*NOT prior_therapy:FGFR_inhibitor
NCT04526899	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:Pembrolizumab; *prior_therapy:anti-PD-1_monoclonal_antibody
NCT04534205	*NOT prior_therapy:Denosumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04538742	*NOT prior_therapy:Tucatinib; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:topoisomerase I inhibitor
NCT04543617	*NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04546009	*NOT prior_therapy:Fulvestrant; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:selective_estrogen-receptor_degrader
NCT04556773	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:mTOR_inhibitor; *NOT prior_therapy:topoisomerase I inhibitor
NCT04565275	*NOT prior_therapy:FGFR_inhibitor
NCT04567615	*NOT prior_therapy:systemic_therapy
NCT04586231	*NOT prior_therapy:Cabozantinib; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04586335	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:mTOR_inhibitor
NCT04597411	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Enzalutamide
NCT04606446	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:endocrine_therapy
NCT04607421	*NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04612751	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04613596	*NOT prior_therapy:immune_checkpoint_blockade
NCT04618393	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT04623775	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04624204	*NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04626479	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:systemic_therapy
NCT04626518	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT04650581	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:mTOR_inhibitor; *NOT prior_therapy:selective_estrogen-receptor_degrader; *NOT prior_therapy:systemic_therapy
NCT04655976	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *prior_therapy:Cisplatin; *prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04656652	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Osimertinib; *prior_therapy:platinum-based_antineoplastic_agent
NCT04662710	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04674683	*NOT prior_therapy:Nivolumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT04675294	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04675333	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04685135	*NOT prior_therapy:Docetaxel
NCT04686305	*NOT prior_therapy:systemic_therapy
NCT04691804	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:systemic_therapy
NCT04702880	*NOT prior_therapy:systemic_therapy
NCT04720768	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT04721015	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04728893	*NOT prior_therapy:PI3K_inhibitor
NCT04729387	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:mTOR_inhibitor; *prior_therapy:platinum-based_antineoplastic_agent
NCT04736706	*NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:systemic_therapy
NCT04737122	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:immune_checkpoint_blockade
NCT04739670	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Gemcitabine; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04739761	*NOT prior_therapy:Tucatinib
NCT04745689	*NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04746924	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04760288	*NOT prior_therapy:Cabozantinib
NCT04784715	*NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:systemic_therapy
NCT04786847	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04789096	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Atezolizumab; *NOT prior_therapy:Avelumab; *NOT prior_therapy:Durvalumab; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:Nivolumab; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:Pertuzumab; *NOT prior_therapy:Taxane; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04793958	*NOT prior_therapy:Cetuximab; *NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:Panitumumab; *NOT prior_therapy:systemic_therapy
NCT04799054	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04801095	*NOT prior_therapy:Cetuximab; *NOT prior_therapy:Crizotinib
NCT04802759	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:Capecitabine; *NOT prior_therapy:Lapatinib; *NOT prior_therapy:Neratinib; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:Pyrotinib; *NOT prior_therapy:Taxane; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:Tucatinib; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:mTOR_inhibitor
NCT04807972	*NOT prior_therapy:systemic_therapy
NCT04811027	*NOT prior_therapy:Ipilimumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04814108	*NOT prior_therapy:immune_checkpoint_blockade
NCT04814875	*prior_therapy:platinum-based_antineoplastic_agent
NCT04821622	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Talazoparib; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04822961	*NOT prior_therapy:Enzalutamide; *NOT prior_therapy:PARP_inhibitor
NCT04830124	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04834973	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:immune_checkpoint_blockade
NCT04835805	*NOT prior_therapy:Atezolizumab; *NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Cobimetinib; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04844073	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Panitumumab; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:Oxaliplatin; *prior_therapy:platinum-based_antineoplastic_agent
NCT04854499	*NOT prior_therapy:Taxane; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04862663	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:Tamoxifen; *NOT prior_therapy:mTOR_inhibitor; *NOT prior_therapy:selective_estrogen-receptor_degrader
NCT04871282	*NOT prior_therapy:Sorafenib
NCT04876651	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04879368	*NOT prior_therapy:Apatinib; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT04895358	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:mTOR_inhibitor
NCT04909125	*NOT prior_therapy:anti-HER2; *NOT prior_therapy:endocrine_therapy
NCT04913285	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor
NCT04914286	*NOT prior_therapy:endocrine_therapy
NCT04918810	*NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Docetaxel
NCT04921358	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:VEGF_inhibitor
NCT04925648	*NOT prior_therapy:Dasatinib
NCT04928846	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04931342	*prior_therapy:platinum-based_antineoplastic_agent
NCT04935359	*NOT prior_therapy:systemic_therapy
NCT04958785	*NOT prior_therapy:Taxane; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:topoisomerase I inhibitor
NCT04964375	*NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:immune_checkpoint_blockade
NCT04964934	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:selective_estrogen-receptor_degrader
NCT04969887	*NOT prior_therapy:Ipilimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT04974398	*NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04975308	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:mTOR_inhibitor; *NOT prior_therapy:selective_estrogen-receptor_degrader
NCT04976634	*NOT prior_therapy:Gemcitabine; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04985604	*NOT prior_therapy:ERK_inhibitor
NCT04985721	*NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade
NCT04986852	*NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04987203	*NOT prior_therapy:immune_checkpoint_blockade
NCT05013099	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05014815	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT05028478	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Erlotinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05040932	*NOT prior_therapy:anti-CD137_monoclonal_antibody
NCT05041257	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05042128	*NOT prior_therapy:systemic_therapy
NCT05043090	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:MET_inhibitor; *NOT prior_therapy:Sunitinib
NCT05052801	*NOT prior_therapy:systemic_therapy
NCT05059262	*NOT prior_therapy:Nilotinib
NCT05061134	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05067283	*NOT prior_therapy:Pembrolizumab
NCT05081609	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT05089734	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05094336	*NOT prior_therapy:Docetaxel
NCT05102214	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT05111626	*NOT prior_therapy:Nivolumab; *NOT prior_therapy:systemic_therapy
NCT05116189	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05116202	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT05117476	*NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05132582	*NOT prior_therapy:Afatinib; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Lapatinib; *NOT prior_therapy:Neratinib; *NOT prior_therapy:Pertuzumab; *NOT prior_therapy:Pyrotinib; *NOT prior_therapy:Taxane; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:Tucatinib; *NOT prior_therapy:anti-HER2
NCT05150236	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05150457	*NOT prior_therapy:immune_checkpoint_blockade
NCT05152147	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05153239	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:topoisomerase I inhibitor
NCT05155254	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:systemic_therapy
NCT05156892	*prior_therapy:platinum-based_antineoplastic_agent
NCT05169697	*NOT prior_therapy:anti-OX40_monoclonal_antibody
NCT05173987	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT05176509	*NOT prior_therapy:Pembrolizumab
NCT05186974	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:systemic_therapy
NCT05188664	*NOT prior_therapy:endocrine_therapy
NCT05198934	*NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:Regorafenib; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05200273	*NOT prior_therapy:Canakinumab
NCT05208944	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05212922	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Sorafenib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05215340	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT05217446	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:Cetuximab; *NOT prior_therapy:Dabrafenib; *NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Encorafenib; *NOT prior_therapy:Panitumumab; *NOT prior_therapy:Vemurafenib; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT05218499	*NOT prior_therapy:systemic_therapy
NCT05221840	*NOT prior_therapy:Durvalumab; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05224141	*NOT prior_therapy:systemic_therapy
NCT05237206	*NOT prior_therapy:immune_checkpoint_blockade
NCT05252364	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:PARP_inhibitor
NCT05253651	*NOT prior_therapy:systemic_therapy
NCT05261399	*NOT prior_therapy:MET_inhibitor; *NOT prior_therapy:Osimertinib; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05266105	*NOT prior_therapy:endocrine_therapy
NCT05267626	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05288166	*NOT prior_therapy:Abemaciclib
NCT05309421	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT05311176	*NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:anti-OX-40_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT05325866	*NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05327530	*NOT prior_therapy:Avelumab; *NOT prior_therapy:Ipilimumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT05328908	*NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:Regorafenib; *NOT prior_therapy:VEGF_inhibitor
NCT05329545	*NOT prior_therapy:mirvetuximab
NCT05330429	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Magrolimab; *NOT prior_therapy:Oxaliplatin; *NOT prior_therapy:immune_checkpoint_blockade
NCT05337137	*NOT prior_therapy:systemic_therapy
NCT05338970	*NOT prior_therapy:EGFR_inhibitor
NCT05340374	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Cabazitaxel; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide
NCT05348577	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:PI3K_inhibitor
NCT05352672	*NOT prior_therapy:systemic_therapy
NCT05355298	*NOT prior_therapy:Gemcitabine; *NOT prior_therapy:Paclitaxel
NCT05359861	*NOT prior_therapy:systemic_therapy
NCT05361395	*NOT prior_therapy:systemic_therapy
NCT05364073	*NOT prior_therapy:Osimertinib; *NOT prior_therapy:Trastuzumab; *NOT prior_therapy:anti-HER2; *NOT prior_therapy:endocrine_therapy; *prior_therapy:platinum-based_antineoplastic_agent
NCT05367440	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Olaparib; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05382286	*NOT prior_therapy:systemic_therapy
NCT05382299	*NOT prior_therapy:systemic_therapy
NCT05383079	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Denosumab; *NOT prior_therapy:Enzalutamide
NCT05383352	*NOT prior_therapy:Gemcitabine
NCT05388669	*NOT prior_therapy:EGFR_inhibitor; *NOT prior_therapy:Osimertinib; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05393791	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Bicalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Denosumab; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Flutamide; *NOT prior_therapy:Nilutamide
NCT05415072	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT05417594	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05419388	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT05425862	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05450692	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05468697	*NOT prior_therapy:Palbociclib; *NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT05486143	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:mTOR_inhibitor
NCT05494918	*NOT prior_therapy:topoisomerase I inhibitor
NCT05501886	*NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:aromatase_inhibitor; *NOT prior_therapy:endocrine_therapy; *NOT prior_therapy:mTOR_inhibitor
NCT05513703	*NOT prior_therapy:systemic_therapy
NCT05521412	*NOT prior_therapy:Abiraterone; *NOT prior_therapy:Apalutamide; *NOT prior_therapy:Darolutamide; *NOT prior_therapy:Enzalutamide; *NOT prior_therapy:Taxane
NCT05537051	*NOT prior_therapy:endocrine_therapy
NCT05544552	*NOT prior_therapy:FGFR_inhibitor
NCT05577715	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05609968	*NOT prior_therapy:systemic_therapy
NCT05613088	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT05614453	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:Denosumab; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT05619913	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT05625399	*NOT prior_therapy:systemic_therapy
NCT05625412	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:EGFR_inhibitor
NCT05694936	*NOT prior_therapy:systemic_therapy
